{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T07:17:52Z","timestamp":1794035872856,"version":"4.8.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"vor","delay-in-days":61,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007436","name":"Familjen Erling-Perssons Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007436","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008599","name":"Alzheimerfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008599","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009673","name":"Gun och Bertil Stohnes Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009673","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Accumulation of amyloid \u03b2-peptide (A\u03b2) is a driver of Alzheimer\u2019s disease (AD). Amyloid precursor protein (\n                    <jats:italic>App<\/jats:italic>\n                    ) knock-in mouse models recapitulate AD-associated A\u03b2 pathology, allowing elucidation of downstream effects of A\u03b2 accumulation and their temporal appearance upon disease progression. Here we have investigated the sequential onset of AD-like pathologies in\n                    <jats:italic>App<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>NL-F<\/jats:italic>\n                    <\/jats:sup>\n                    and\n                    <jats:italic>App<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>NL-G-F<\/jats:italic>\n                    <\/jats:sup>\n                    knock-in mice by time-course transcriptome analysis of hippocampus, a region severely affected in AD. Strikingly, energy metabolism emerged as one of the most significantly altered pathways already at an early stage of pathology. Functional experiments in isolated mitochondria from hippocampus of both\n                    <jats:italic>App<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>NL-F<\/jats:italic>\n                    <\/jats:sup>\n                    and\n                    <jats:italic>App<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>NL-G-F<\/jats:italic>\n                    <\/jats:sup>\n                    mice confirmed an upregulation of oxidative phosphorylation driven by the activity of mitochondrial complexes I, IV and V, associated with higher susceptibility to oxidative damage and Ca\n                    <jats:sup>2+<\/jats:sup>\n                    -overload. Upon increasing pathologies, the brain shifts to a state of hypometabolism with reduced abundancy of mitochondria in presynaptic terminals. These late-stage mice also displayed enlarged presynaptic areas associated with abnormal accumulation of synaptic vesicles and autophagosomes, the latter ultimately leading to local autophagy impairment in the synapses. In summary, we report that A\u03b2-induced pathways in\n                    <jats:italic>App<\/jats:italic>\n                    knock-in mouse models recapitulate key pathologies observed in AD brain, and our data herein adds a comprehensive understanding of the pathologies including dysregulated metabolism and synapses and their timewise appearance to find new therapeutic approaches for AD.\n                  <\/jats:p>","DOI":"10.1038\/s41380-023-02289-4","type":"journal-article","created":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T22:02:19Z","timestamp":1698789739000},"page":"3966-3981","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":84,"title":["Mitochondrial hypermetabolism precedes impaired autophagy and synaptic disorganization in App knock-in Alzheimer mouse models"],"prefix":"10.1038","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0886-4634","authenticated-orcid":false,"given":"Luana","family":"Naia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9618-0533","authenticated-orcid":false,"given":"Makoto","family":"Shimozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Bereczki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xidan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7336-3895","authenticated-orcid":false,"given":"Jianping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5184-4172","authenticated-orcid":false,"given":"Richeng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Giraud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuno Santos","family":"Leal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catarina Moreira","family":"Pinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria Lim","family":"Falk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Dentoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Ankarcrona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6450-0870","authenticated-orcid":false,"given":"Per","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,1]]},"reference":[{"key":"2289_CR1","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0197-4580(95)00021-6","volume":"16","author":"H Braak","year":"1995","unstructured":"Braak H, Braak E. Staging of Alzheimer\u2019s disease-related neurofibrillary changes. Neurobiol Aging. 1995;16:271\u20138.","journal-title":"Neurobiol Aging"},{"key":"2289_CR2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.celrep.2013.08.042","volume":"5","author":"P Nilsson","year":"2013","unstructured":"Nilsson P, Loganathan K, Sekiguchi M, Matsuba Y, Hui K, Tsubuki S, et al. Abeta secretion and plaque formation depend on autophagy. Cell Rep. 2013;5:61\u20139.","journal-title":"Cell Rep"},{"key":"2289_CR3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, et al. Lecanemab in early Alzheimer\u2019s disease. N. Engl J Med. 2023;388:9\u201321.","journal-title":"N. Engl J Med"},{"key":"2289_CR4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41582-019-0295-9","volume":"16","author":"R Howard","year":"2020","unstructured":"Howard R, Liu KY. Questions EMERGE as Biogen claims aducanumab turnaround. Nat Rev Neurol. 2020;16:63\u20134.","journal-title":"Nat Rev Neurol"},{"key":"2289_CR5","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S1474-4422(16)00062-4","volume":"15","author":"B Winblad","year":"2016","unstructured":"Winblad B, Amouyel P, Andrieu S, Ballard C, Brayne C, Brodaty H, et al. Defeating Alzheimer\u2019s disease and other dementias: a priority for European science and society. Lancet Neurol. 2016;15:455\u2013532.","journal-title":"Lancet Neurol"},{"key":"2289_CR6","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/s41591-020-0815-6","volume":"26","author":"ECB Johnson","year":"2020","unstructured":"Johnson ECB, Dammer EB, Duong DM, Ping L, Zhou M, Yin L, et al. Large-scale proteomic analysis of Alzheimer\u2019s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation. Nat Med. 2020;26:769\u201380.","journal-title":"Nat Med"},{"key":"2289_CR7","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41386-020-00840-3","volume":"46","author":"S Rayaprolu","year":"2021","unstructured":"Rayaprolu S, Higginbotham L, Bagchi P, Watson CM, Zhang T, Levey AI, et al. Systems-based proteomics to resolve the biology of Alzheimer\u2019s disease beyond amyloid and tau. Neuropsychopharmacology. 2021;46:98\u2013115.","journal-title":"Neuropsychopharmacology"},{"key":"2289_CR8","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.cels.2016.11.006","volume":"4","author":"NT Seyfried","year":"2017","unstructured":"Seyfried NT, Dammer EB, Swarup V, Nandakumar D, Duong DM, Yin L, et al. A multi-network approach identifies protein-specific co-expression in asymptomatic and symptomatic Alzheimer\u2019s disease. Cell Syst. 2017;4:60\u201372.e64.","journal-title":"Cell Syst"},{"key":"2289_CR9","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.scr.2018.01.019","volume":"27","author":"JH Birnbaum","year":"2018","unstructured":"Birnbaum JH, Wanner D, Gietl AF, Saake A, K\u00fcndig TM, Hock C, et al. Oxidative stress and altered mitochondrial protein expression in the absence of amyloid-\u03b2 and tau pathology in iPSC-derived neurons from sporadic Alzheimer\u2019s disease patients. Stem Cell Res. 2018;27:121\u201330.","journal-title":"Stem Cell Res"},{"key":"2289_CR10","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3233\/JAD-220383","volume":"90","author":"G Dentoni","year":"2022","unstructured":"Dentoni G, Naia L, Portal B, Leal NS, Nilsson P, Lindskog M, et al. Mitochondrial alterations in neurons derived from the murine AppNL-F knock-in model of Alzheimer\u2019s disease. J Alzheimers Dis. 2022;90:565\u201383.","journal-title":"J Alzheimers Dis"},{"key":"2289_CR11","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00259-014-2919-z","volume":"42","author":"A Ashraf","year":"2015","unstructured":"Ashraf A, Fan Z, Brooks DJ, Edison P. Cortical hypermetabolism in MCI subjects: a compensatory mechanism? Eur J Nucl Med Mol Imaging. 2015;42:447\u201358.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2289_CR12","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1073\/pnas.96.6.3053","volume":"96","author":"SF Lichtenthaler","year":"1999","unstructured":"Lichtenthaler SF, Wang R, Grimm H, Uljon SN, Masters CL, Beyreuther K. Mechanism of the cleavage specificity of Alzheimer\u2019s disease \u03b3-secretase identified by phenylalanine-scanning mutagenesis of the transmembrane domain of the amyloid precursor protein. Proc Natl Acad Sci. 1999;96:3053\u20138.","journal-title":"Proc Natl Acad Sci"},{"key":"2289_CR13","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/NEN.0b013e3181c6b84d","volume":"69","author":"C Guardia-Laguarta","year":"2010","unstructured":"Guardia-Laguarta C, Pera M, Clarim\u00f3n J, Molinuevo JL, S\u00e0nchez-Valle R, Llad\u00f3 A, et al. Clinical, neuropathologic, and biochemical profile of the amyloid precursor protein I716F mutation. J Neuropathol Exp Neurol. 2010;69:53\u20139.","journal-title":"J Neuropathol Exp Neurol"},{"key":"2289_CR14","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nn.3697","volume":"17","author":"T Saito","year":"2014","unstructured":"Saito T, Matsuba Y, Mihira N, Takano J, Nilsson P, Itohara S, et al. Single App knock-in mouse models of Alzheimer\u2019s disease. Nat Neurosci. 2014;17:661\u20133.","journal-title":"Nat Neurosci"},{"key":"2289_CR15","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.15252\/embj.201797397","volume":"36","author":"H Sasaguri","year":"2017","unstructured":"Sasaguri H, Nilsson P, Hashimoto S, Nagata K, Saito T, De Strooper B, et al. APP mouse models for Alzheimer\u2019s disease preclinical studies. EMBO J. 2017;36:2473.","journal-title":"EMBO J"},{"key":"2289_CR16","volume":"14","author":"D Kim","year":"2013","unstructured":"Kim D, Pertea G, Trapnell C, Pimentel H, Kelley R, Salzberg SL. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol. 2013;14:R36.","journal-title":"Genome Biol"},{"key":"2289_CR17","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012;9:357\u20139.","journal-title":"Nat Methods"},{"key":"2289_CR18","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao Y, Smyth GK, Shi W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30:923\u201330.","journal-title":"Bioinformatics"},{"key":"2289_CR19","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.","journal-title":"Genome Biol"},{"key":"2289_CR20","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/ng1180","volume":"34","author":"VK Mootha","year":"2003","unstructured":"Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet. 2003;34:267\u201373.","journal-title":"Nat Genet"},{"key":"2289_CR21","doi-asserted-by":"crossref","unstructured":"Krijthe JH. Rtsne: T-Distributed Stochastic Neighbor Embedding using Barnes-Hut Implementation. 2015. R package version 0.16, https:\/\/github.com\/jkrijthe\/Rtsne.","DOI":"10.32614\/CRAN.package.Rtsne"},{"key":"2289_CR22","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/978-1-4939-7825-0_19","volume":"1780","author":"IL Ferreira","year":"2018","unstructured":"Ferreira IL, Carmo C, Naia L, I Mota S, Cristina Rego A. Assessing mitochondrial function in in vitro and ex vivo models of Huntington\u2019s disease. Methods Mol Biol. 2018;1780:415\u201342.","journal-title":"Methods Mol Biol"},{"key":"2289_CR23","doi-asserted-by":"crossref","first-page":"e21746","DOI":"10.1371\/journal.pone.0021746","volume":"6","author":"GW Rogers","year":"2011","unstructured":"Rogers GW, Brand MD, Petrosyan S, Ashok D, Elorza AA, Ferrick DA, et al. High throughput microplate respiratory measurements using minimal quantities of isolated mitochondria. Plos One. 2011;6:e21746.","journal-title":"Plos One"},{"key":"2289_CR24","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/jnc.13165","volume":"134","author":"JJ Pellman","year":"2015","unstructured":"Pellman JJ, Hamilton J, Brustovetsky T, Brustovetsky N. Ca(2+) handling in isolated brain mitochondria and cultured neurons derived from the YAC128 mouse model of Huntington\u2019s disease. J Neurochem. 2015;134:652\u201367.","journal-title":"J Neurochem"},{"key":"2289_CR25","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1021\/cn500105p","volume":"5","author":"P Nilsson","year":"2014","unstructured":"Nilsson P, Saito T, Saido TC. New mouse model of Alzheimer\u2019s. ACS Chem Neurosci. 2014;5:499\u2013502.","journal-title":"ACS Chem Neurosci"},{"key":"2289_CR26","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/s41593-018-0154-9","volume":"21","author":"S Mostafavi","year":"2018","unstructured":"Mostafavi S, Gaiteri C, Sullivan SE, White CC, Tasaki S, Xu J, et al. A molecular network of the aging human brain provides insights into the pathology and cognitive decline of Alzheimer\u2019s disease. Nat Neurosci. 2018;21:811\u20139.","journal-title":"Nat Neurosci"},{"key":"2289_CR27","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.exger.2014.03.006","volume":"56","author":"A Hofer","year":"2014","unstructured":"Hofer A, Wenz T. Post-translational modification of mitochondria as a novel mode of regulation. Exp Gerontol. 2014;56:202\u201320.","journal-title":"Exp Gerontol"},{"key":"2289_CR28","doi-asserted-by":"crossref","first-page":"13063","DOI":"10.1073\/pnas.1613701113","volume":"113","author":"I Lopez-Fabuel","year":"2016","unstructured":"Lopez-Fabuel I, Le Douce J, Logan A, James AM, Bonvento G, Murphy MP, et al. Complex I assembly into supercomplexes determines differential mitochondrial ROS production in neurons and astrocytes. Proc Natl Acad Sci USA. 2016;113:13063\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2289_CR29","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1073\/pnas.93.7.2719","volume":"93","author":"M Hoshi","year":"1996","unstructured":"Hoshi M, Takashima A, Noguchi K, Murayama M, Sato M, Kondo S, et al. Regulation of mitochondrial pyruvate dehydrogenase activity by tau protein kinase I\/glycogen synthase kinase 3beta in brain. Proc Natl Acad Sci USA. 1996;93:2719\u201323.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2289_CR30","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/sj.mp.4002077","volume":"13","author":"C Schmidt","year":"2008","unstructured":"Schmidt C, Lepsverdize E, Chi SL, Das AM, Pizzo SV, Dityatev A, et al. Amyloid precursor protein and amyloid beta-peptide bind to ATP synthase and regulate its activity at the surface of neural cells. Mol Psychiatry. 2008;13:953\u201369.","journal-title":"Mol Psychiatry"},{"key":"2289_CR31","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0014-5793(99)01028-5","volume":"457","author":"L Canevari","year":"1999","unstructured":"Canevari L, Clark JB, Bates TE. beta-Amyloid fragment 25-35 selectively decreases complex IV activity in isolated mitochondria. FEBS Lett. 1999;457:131\u20134.","journal-title":"FEBS Lett"},{"key":"2289_CR32","volume":"4","author":"J Qiu","year":"2013","unstructured":"Qiu J, Tan YW, Hagenston AM, Martel MA, Kneisel N, Skehel PA, et al. Mitochondrial calcium uniporter Mcu controls excitotoxicity and is transcriptionally repressed by neuroprotective nuclear calcium signals. Nat Commun. 2013;4:2034.","journal-title":"Nat Commun"},{"key":"2289_CR33","doi-asserted-by":"crossref","DOI":"10.1186\/s40478-021-01216-4","volume":"9","author":"C Emre","year":"2021","unstructured":"Emre C, Do KV, Jun B, Hjorth E, Alcalde SG, Kautzmann M-AI, et al. Age-related changes in brain phospholipids and bioactive lipids in the APP knock-in mouse model of Alzheimer\u2019s disease. Acta Neuropathol Commun. 2021;9:116.","journal-title":"Acta Neuropathol Commun"},{"key":"2289_CR34","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1038\/s41401-022-00879-6","volume":"43","author":"M-M Lin","year":"2022","unstructured":"Lin M-M, Liu N, Qin Z-H, Wang Y. Mitochondrial-derived damage-associated molecular patterns amplify neuroinflammation in neurodegenerative diseases. Acta Pharmacol Sin. 2022;43:2439\u201347.","journal-title":"Acta Pharmacol Sin"},{"key":"2289_CR35","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.3390\/cells9122552","volume":"9","author":"NS Leal","year":"2020","unstructured":"Leal NS, Dentoni G, Schreiner B, Naia L, Piras A, Graff C, et al. Amyloid beta-peptide increases mitochondria-endoplasmic reticulum contact altering mitochondrial function and autophagosome formation in Alzheimer\u2019s disease-related models. Cells. 2020;9:2552.","journal-title":"Cells"},{"key":"2289_CR36","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.cell.2010.05.008","volume":"141","author":"J-H Lee","year":"2010","unstructured":"Lee J-H, Yu WH, Kumar A, Lee S, Mohan PS, Peterhoff CM, et al. Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations. Cell. 2010;141:1146\u201358.","journal-title":"Cell"},{"key":"2289_CR37","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/jnen\/64.2.113","volume":"64","author":"RA Nixon","year":"2005","unstructured":"Nixon RA, Wegiel J, Kumar A, Yu WH, Peterhoff C, Cataldo A, et al. Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study. J Neuropathol Exp Neurol. 2005;64:113\u201322.","journal-title":"J Neuropathol Exp Neurol"},{"key":"2289_CR38","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s12035-013-8505-8","volume":"49","author":"C Wang","year":"2014","unstructured":"Wang C, Yu JT, Miao D, Wu ZC, Tan MS, Tan L. Targeting the mTOR signaling network for Alzheimer\u2019s disease therapy. Mol Neurobiol. 2014;49:120\u201335.","journal-title":"Mol Neurobiol"},{"key":"2289_CR39","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.15252\/embr.201744069","volume":"18","author":"I Kjos","year":"2017","unstructured":"Kjos I, Borg Distefano M, S\u00e6tre F, Repnik U, Holland P, Jones AT, et al. Rab7b modulates autophagic flux by interacting with Atg4B. EMBO Rep. 2017;18:1727\u201339.","journal-title":"EMBO Rep"},{"key":"2289_CR40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15548627.2020.1797280","volume":"17","author":"DJ Klionsky","year":"2021","unstructured":"Klionsky DJ, Abdel-Aziz AK, Abdelfatah S, Abdellatif M, Abdoli A, Abel S, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)(1). Autophagy. 2021;17:1\u2013382.","journal-title":"Autophagy"},{"key":"2289_CR41","doi-asserted-by":"crossref","unstructured":"Pang K, Jiang R, Zhang W, Yang Z, Li L-L, Shimozawa M, et al. An App knock-in rat model for Alzheimer\u2019s disease exhibiting A\u03b2 and tau pathologies, neuronal death and cognitive impairments. Cell Res. 2022;32:157\u201375.","DOI":"10.1038\/s41422-021-00582-x"},{"key":"2289_CR42","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.molcel.2011.07.039","volume":"44","author":"G Matsumoto","year":"2011","unstructured":"Matsumoto G, Wada K, Okuno M, Kurosawa M, Nukina N. Serine 403 phosphorylation of p62\/SQSTM1 regulates selective autophagic clearance of ubiquitinated proteins. Mol Cell. 2011;44:279\u201389.","journal-title":"Mol Cell"},{"key":"2289_CR43","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1126\/science.1196371","volume":"331","author":"F Egan Daniel","year":"2011","unstructured":"Egan Daniel F, Shackelford David B, Mihaylova Maria M, Gelino S, Kohnz Rebecca A, Mair W, et al. Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science. 2011;331:456\u201361.","journal-title":"Science"},{"key":"2289_CR44","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/ncb2152","volume":"13","author":"J Kim","year":"2011","unstructured":"Kim J, Kundu M, Viollet B, Guan K-L. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol. 2011;13:132\u201341.","journal-title":"Nat Cell Biol"},{"key":"2289_CR45","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1046\/j.1471-4159.1994.63062179.x","volume":"63","author":"EM Mutisya","year":"1994","unstructured":"Mutisya EM, Bowling AC, Beal MF. Cortical cytochrome oxidase activity is reduced in Alzheimer\u2019s disease. J Neurochem. 1994;63:2179\u201384.","journal-title":"J Neurochem"},{"key":"2289_CR46","volume":"11","author":"J Cheng","year":"2021","unstructured":"Cheng J, Liu H-P, Lin W-Y, Tsai F-J. Machine learning compensates fold-change method and highlights oxidative phosphorylation in the brain transcriptome of Alzheimer\u2019s disease. Sci Rep. 2021;11:13704.","journal-title":"Sci Rep"},{"key":"2289_CR47","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nature05292","volume":"443","author":"MT Lin","year":"2006","unstructured":"Lin MT, Beal MF. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature. 2006;443:787\u201395.","journal-title":"Nature"},{"key":"2289_CR48","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jalz.2016.09.003","volume":"13","author":"D Mastroeni","year":"2017","unstructured":"Mastroeni D, Khdour OM, Delvaux E, Nolz J, Olsen G, Berchtold N, et al. Nuclear but not mitochondrial-encoded oxidative phosphorylation genes are altered in aging, mild cognitive impairment, and Alzheimer\u2019s disease. Alzheimers Dement. 2017;13:510\u20139.","journal-title":"Alzheimers Dement"},{"key":"2289_CR49","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1385\/NMM:5:2:147","volume":"5","author":"M Manczak","year":"2004","unstructured":"Manczak M, Park BS, Jung Y, Reddy PH. Differential expression of oxidative phosphorylation genes in patients with Alzheimer\u2019s disease: implications for early mitochondrial dysfunction and oxidative damage. Neuromol Med. 2004;5:147\u201362.","journal-title":"Neuromol Med"},{"key":"2289_CR50","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s10522-012-9403-6","volume":"13","author":"LA Demetrius","year":"2012","unstructured":"Demetrius LA, Simon DK. An inverse-Warburg effect and the origin of Alzheimer\u2019s disease. Biogerontology. 2012;13:583\u201394.","journal-title":"Biogerontology"},{"key":"2289_CR51","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13195-020-00667-6","volume":"12","author":"A Latif-Hernandez","year":"2020","unstructured":"Latif-Hernandez A, Sabanov V, Ahmed T, Craessaerts K, Saito T, Saido T, et al. The two faces of synaptic failure in AppNL-G-F knock-in mice. Alzheimer\u2019s Res Ther. 2020;12:100.","journal-title":"Alzheimer\u2019s Res Ther"},{"key":"2289_CR52","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/s41593-023-01325-4","volume":"26","author":"S Calafate","year":"2023","unstructured":"Calafate S, \u00d6zturan G, Thrupp N, Vanderlinden J, Santa-Marinha L, Morais-Ribeiro R, et al. Early alterations in the MCH system link aberrant neuronal activity and sleep disturbances in a mouse model of Alzheimer\u2019s disease. Nat Neurosci. 2023;26:1021\u201331.","journal-title":"Nat Neurosci"},{"key":"2289_CR53","doi-asserted-by":"crossref","first-page":"111280","DOI":"10.1016\/j.celrep.2022.111280","volume":"40","author":"D Shah","year":"2022","unstructured":"Shah D, Gsell W, Wahis J, Luckett ES, Jamoulle T, Vermaercke B, et al. Astrocyte calcium dysfunction causes early network hyperactivity in Alzheimer\u2019s disease. Cell Rep. 2022;40:111280.","journal-title":"Cell Rep"},{"key":"2289_CR54","doi-asserted-by":"crossref","first-page":"13145","DOI":"10.1073\/pnas.0806192105","volume":"105","author":"CA Hansson Petersen","year":"2008","unstructured":"Hansson Petersen CA, Alikhani N, Behbahani H, Wiehager B, Pavlov PF, Alafuzoff I, et al. The amyloid beta-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae. Proc Natl Acad Sci USA. 2008;105:13145\u201350.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2289_CR55","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1523\/JNEUROSCI.21-09-03017.2001","volume":"21","author":"K Hirai","year":"2001","unstructured":"Hirai K, Aliev G, Nunomura A, Fujioka H, Russell RL, Atwood CS, et al. Mitochondrial abnormalities in Alzheimer\u2019s disease. J Neurosci. 2001;21:3017\u201323.","journal-title":"J Neurosci"},{"key":"2289_CR56","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.immuni.2012.01.009","volume":"36","author":"K Shimada","year":"2012","unstructured":"Shimada K, Crother Timothy R, Karlin J, Dagvadorj J, Chiba N, Chen S, et al. Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity. 2012;36:401\u201314.","journal-title":"Immunity"},{"key":"2289_CR57","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s41583-019-0132-6","volume":"20","author":"DA Butterfield","year":"2019","unstructured":"Butterfield DA, Halliwell B. Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease. Nat Rev Neurosci. 2019;20:148\u201360.","journal-title":"Nat Rev Neurosci"},{"key":"2289_CR58","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.neurobiolaging.2018.01.002","volume":"65","author":"I Apostolova","year":"2018","unstructured":"Apostolova I, Lange C, M\u00e4urer A, Suppa P, Spies L, Grothe MJ, et al. Hypermetabolism in the hippocampal formation of cognitively impaired patients indicates detrimental maladaptation. Neurobiol Aging. 2018;65:41\u201350.","journal-title":"Neurobiol Aging"},{"key":"2289_CR59","doi-asserted-by":"crossref","first-page":"14770","DOI":"10.1523\/JNEUROSCI.3669-09.2009","volume":"29","author":"DC Ann","year":"2009","unstructured":"Ann DC, Julie CP, Lisa AW, Jeffrey J, Bedda LR, Wenzhu B, et al. Basal cerebral metabolism may modulate the cognitive effects of A\u03b2 in mild cognitive impairment: an example of brain reserve. J Neurosci. 2009;29:14770.","journal-title":"J Neurosci"},{"key":"2289_CR60","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-11813-6","volume":"10","author":"P Jadiya","year":"2019","unstructured":"Jadiya P, Kolmetzky DW, Tomar D, Di Meco A, Lombardi AA, Lambert JP, et al. Impaired mitochondrial calcium efflux contributes to disease progression in models of Alzheimer\u2019s disease. Nat Commun. 2019;10:3885.","journal-title":"Nat Commun"},{"key":"2289_CR61","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-16074-2","volume":"11","author":"M Calvo-Rodriguez","year":"2020","unstructured":"Calvo-Rodriguez M, Hou SS, Snyder AC, Kharitonova EK, Russ AN, Das S, et al. Increased mitochondrial calcium levels associated with neuronal death in a mouse model of Alzheimer\u2019s disease. Nat Commun. 2020;11:2146.","journal-title":"Nat Commun"},{"key":"2289_CR62","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17999-3","volume":"7","author":"E Castillo","year":"2017","unstructured":"Castillo E, Leon J, Mazzei G, Abolhassani N, Haruyama N, Saito T, et al. Comparative profiling of cortical gene expression in Alzheimer\u2019s disease patients and mouse models demonstrates a link between amyloidosis and neuroinflammation. Sci Rep. 2017;7:17762.","journal-title":"Sci Rep"},{"key":"2289_CR63","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1211103","volume":"368","author":"T Jonsson","year":"2013","unstructured":"Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson PV, Snaedal J, et al. Variant of TREM2 associated with the risk of Alzheimer\u2019s disease. N. Engl J Med. 2013;368:107\u201316.","journal-title":"N. Engl J Med"},{"key":"2289_CR64","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41582-019-0228-7","volume":"15","author":"Y Yamazaki","year":"2019","unstructured":"Yamazaki Y, Zhao N, Caulfield TR, Liu C-C, Bu G, Apolipoprotein E. and Alzheimer disease: pathobiology and targeting strategies. Nat Rev Neurol. 2019;15:501\u201318.","journal-title":"Nat Rev Neurol"},{"key":"2289_CR65","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nature11729","volume":"493","author":"MT Heneka","year":"2013","unstructured":"Heneka MT, Kummer MP, Stutz A, Delekate A, Schwartz S, Vieira-Saecker A, et al. NLRP3 is activated in Alzheimer\u2019s disease and contributes to pathology in APP\/PS1 mice. Nature. 2013;493:674\u20138.","journal-title":"Nature"},{"key":"2289_CR66","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.immuni.2022.06.007","volume":"55","author":"H Xian","year":"2022","unstructured":"Xian H, Watari K, Sanchez-Lopez E, Offenberger J, Onyuru J, Sampath H, et al. Oxidized DNA fragments exit mitochondria via mPTP- and VDAC-dependent channels to activate NLRP3 inflammasome and interferon signaling. Immunity. 2022;55:1370\u201385.","journal-title":"Immunity"},{"key":"2289_CR67","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.tem.2021.09.004","volume":"32","author":"LA Demetrius","year":"2021","unstructured":"Demetrius LA, Eckert A, Grimm A. Sex differences in Alzheimer\u2019s disease: metabolic reprogramming and therapeutic intervention. Trends Endocrinol Metab. 2021;32:963\u201379.","journal-title":"Trends Endocrinol Metab"},{"key":"2289_CR68","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/s42003-021-02259-y","volume":"4","author":"M-V Guillot-Sestier","year":"2021","unstructured":"Guillot-Sestier M-V, Araiz AR, Mela V, Gaban AS, O\u2019Neill E, Joshi L, et al. Microglial metabolism is a pivotal factor in sexual dimorphism in Alzheimer\u2019s disease. Commun Biol. 2021;4:711.","journal-title":"Commun Biol"},{"key":"2289_CR69","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.cell.2013.12.042","volume":"156","author":"V Rangaraju","year":"2014","unstructured":"Rangaraju V, Calloway N, Ryan TA, Activity-Driven Local ATP. Synthesis is required for synaptic function. Cell. 2014;156:825\u201335.","journal-title":"Cell"},{"key":"2289_CR70","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-38412-7","volume":"9","author":"M Borczyk","year":"2019","unstructured":"Borczyk M, \u015aliwi\u0144ska MA, Caly A, Bernas T, Radwanska K. Neuronal plasticity affects correlation between the size of dendritic spine and its postsynaptic density. Sci Rep. 2019;9:1693.","journal-title":"Sci Rep"},{"key":"2289_CR71","doi-asserted-by":"crossref","first-page":"13275","DOI":"10.1523\/JNEUROSCI.1034-15.2015","volume":"35","author":"H Zhang","year":"2015","unstructured":"Zhang H, Wu L, Pchitskaya E, Zakharova O, Saito T, Saido T, et al. Neuronal store-operated calcium entry and mushroom spine loss in amyloid precursor protein knock-in mouse model of Alzheimer\u2019s Disease. J Neurosci. 2015;35:13275.","journal-title":"J Neurosci"},{"key":"2289_CR72","doi-asserted-by":"crossref","unstructured":"Arroyo-Garc\u00eda LE, Isla AG, Andrade-Talavera Y, Balleza-Tapia H, Loera-Valencia R, Alvarez-Jimenez L, et al. Impaired spike-gamma coupling of area CA3 fast-spiking interneurons as the earliest functional impairment in the AppNL-G-F mouse model of Alzheimer\u2019s disease. Mol Psychiatry. 2021;26:5557\u201367.","DOI":"10.1038\/s41380-021-01257-0"},{"key":"2289_CR73","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.neuron.2020.01.018","volume":"105","author":"SE Hill","year":"2020","unstructured":"Hill SE, Col\u00f3n-Ramos DA. The journey of the synaptic autophagosome: a cell biological perspective. Neuron. 2020;105:961\u201373.","journal-title":"Neuron"},{"key":"2289_CR74","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/s41593-018-0332-9","volume":"22","author":"EF Fang","year":"2019","unstructured":"Fang EF, Hou Y, Palikaras K, Adriaanse BA, Kerr JS, Yang B, et al. Mitophagy inhibits amyloid-\u03b2 and tau pathology and reverses cognitive deficits in models of Alzheimer\u2019s disease. Nat Neurosci. 2019;22:401\u201312.","journal-title":"Nat Neurosci"},{"key":"2289_CR75","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/s41419-021-04237-y","volume":"12","author":"JV Andersen","year":"2021","unstructured":"Andersen JV, Skotte NH, Christensen SK, Polli FS, Shabani M, Markussen KH, et al. Hippocampal disruptions of synaptic and astrocyte metabolism are primary events of early amyloid pathology in the 5xFAD mouse model of Alzheimer\u2019s disease. Cell Death Dis. 2021;12:954.","journal-title":"Cell Death Dis"},{"key":"2289_CR76","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s41593-022-01084-8","volume":"25","author":"J-H Lee","year":"2022","unstructured":"Lee J-H, Yang D-S, Goulbourne CN, Im E, Stavrides P, Pensalfini A, et al. Faulty autolysosome acidification in Alzheimer\u2019s disease mouse models induces autophagic build-up of A\u03b2 in neurons, yielding senile plaques. Nat Neurosci. 2022;25:688\u2013701.","journal-title":"Nat Neurosci"},{"key":"2289_CR77","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.cels.2020.11.007","volume":"12","author":"TJ Hark","year":"2021","unstructured":"Hark TJ, Rao NR, Castillon C, Basta T, Smukowski S, Bao H, et al. Pulse-chase proteomics of the app knockin mouse models of Alzheimer\u2019s disease reveals that synaptic dysfunction originates in presynaptic terminals. Cell Syst. 2021;12:141\u201358.","journal-title":"Cell Syst"},{"key":"2289_CR78","doi-asserted-by":"crossref","first-page":"e98044","DOI":"10.15252\/embj.201798044","volume":"37","author":"S Truckenbrodt","year":"2018","unstructured":"Truckenbrodt S, Viplav A, J\u00e4hne S, Vogts A, Denker A, Wildhagen H, et al. Newly produced synaptic vesicle proteins are preferentially used in synaptic transmission. EMBO J. 2018;37:e98044.","journal-title":"EMBO J"},{"key":"2289_CR79","doi-asserted-by":"crossref","first-page":"e56590","DOI":"10.7554\/eLife.56590","volume":"9","author":"S Hoffmann-Conaway","year":"2020","unstructured":"Hoffmann-Conaway S, Brockmann MM, Schneider K, Annamneedi A, Rahman KA, Bruns C, et al. Parkin contributes to synaptic vesicle autophagy in Bassoon-deficient mice. eLife. 2020;9:e56590.","journal-title":"eLife"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-023-02289-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-023-02289-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-023-02289-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:59:41Z","timestamp":1730422781000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-023-02289-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":79,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["2289"],"URL":"https:\/\/doi.org\/10.1038\/s41380-023-02289-4","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"17 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}